Type of culture medium determines properties of cultivated retinal endothelial cells: induction of substantial phenotypic conversion by standard DMEM.

Barrier dysfunction Cell culture medium Cell index measurements Cell type conversion DMEM ECGM-MV Endothelial cells Paracellular flow Phenotype Retinal endothelial cells Transcellular transport

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 29 09 2020
revised: 22 12 2020
accepted: 15 01 2021
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 2 2 2021
Statut: epublish

Résumé

Contradictory behavior of microvascular retinal endothelial cells (REC) - a reliable in vitro model to study retinal diseases - have recently been reported which might result from cultivating the cells in standard DMEM not optimized for this cell type. Therefore, we studied DMEM's effects on phenotype and behavior of immortalized bovine REC. Cells were cultivated in endothelial cell growth medium (ECGM) until a confluent monolayer was reached and then further kept for 1-4 days in ECGM, DMEM, or mixes thereof all supplemented with 5% fetal bovine serum, endothelial cell growth supplement, 90 μg/ml heparin, and 100 nM hydrocortisone. Within hours of cultivation in DMEM, the cell index - measured to assess the cell layer's barrier function - dropped to ~5% of the initial value and only slowly recovered, not only accompanied by stronger expression of HSP70 mRNA and secretion of interleukin-6, but also by lower expressions of tight junction proteins claudin-5, claudin-1 or of the marker of cell type conversion caveolin-1. Altered subcellular localizations of EC-typic claudin-5, vascular endothelial cadherin and von Willebrand factor were also observed. Taken together, all experiments with (retinal) EC cultivated in common DMEM need to be interpreted very cautiously and should at least include phenotypic validation.

Identifiants

pubmed: 33521368
doi: 10.1016/j.heliyon.2021.e06037
pii: S2405-8440(21)00142-0
pmc: PMC7820930
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e06037

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Invest Ophthalmol Vis Sci. 1999 Jan;40(1):182-9
pubmed: 9888442
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):489-500
pubmed: 23288152
J Neurochem. 2002 Feb;80(4):667-77
pubmed: 11841574
Hum Cell. 1996 Sep;9(3):181-6
pubmed: 9183647
Br J Ophthalmol. 2012 Jan;96(1):128-32
pubmed: 22028475
Exp Eye Res. 2020 Sep;198:108156
pubmed: 32712182
J Diabetes Res. 2020 May 25;2020:2450781
pubmed: 32566677
FASEB J. 2014 Sep;28(9):3823-31
pubmed: 24858278
Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2408-13
pubmed: 11527957
Ann N Y Acad Sci. 1982;401:163-70
pubmed: 6820245
Int J Nanomedicine. 2016 Jul 07;11:3101-9
pubmed: 27462154
J Ethnopharmacol. 2016 Jun 5;185:162-70
pubmed: 26988565
J Cell Biol. 1999 Oct 4;147(1):185-94
pubmed: 10508865
N Engl J Med. 1977 Feb 17;296(7):377-83
pubmed: 299915
Graefes Arch Clin Exp Ophthalmol. 2013 Oct;251(10):2345-53
pubmed: 23760670
Anal Biochem. 2012 Jun 15;425(2):96-103
pubmed: 22449498
Dev Cell. 2009 Feb;16(2):209-21
pubmed: 19217423
In Vitro Cell Dev Biol. 1987 Jul;23(7):481-91
pubmed: 3301790
Exp Eye Res. 2008 Jun;86(6):867-78
pubmed: 18501346
FASEB J. 2019 Dec;33(12):13695-13709
pubmed: 31585507
Exp Eye Res. 2016 Oct;151:75-81
pubmed: 27523466
Exp Eye Res. 2011 Nov;93(5):761-6
pubmed: 21970900
J Biomol Screen. 2005 Dec;10(8):795-805
pubmed: 16234347
Sci Rep. 2016 Mar 30;6:23671
pubmed: 27025965
Cell Physiol Biochem. 2017;42(4):1493-1513
pubmed: 28719888
J Exp Med. 2006 Dec 25;203(13):2895-906
pubmed: 17178917
Am J Physiol Cell Physiol. 2017 May 1;312(5):C624-C626
pubmed: 28228375
Diabetes. 2010 Nov;59(11):2872-82
pubmed: 20693346
Am J Respir Cell Mol Biol. 1991 Sep;5(3):265-75
pubmed: 1910812
Biomed Pharmacother. 2018 Jun;102:833-838
pubmed: 29605771
Exp Eye Res. 2020 May;194:108004
pubmed: 32184103
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):535-42
pubmed: 19643968
Int J Mol Med. 2005 Jul;16(1):65-70
pubmed: 15942679
J Biol Chem. 1999 Aug 13;274(33):23463-7
pubmed: 10438525
Exp Eye Res. 2002 Apr;74(4):523-35
pubmed: 12076096
Virology. 1959 Jul;8(3):396-7
pubmed: 13669362
Exp Eye Res. 2013 Oct;115:162-71
pubmed: 23891860
Cytokine. 2013 Nov;64(2):605-12
pubmed: 24026137
Invest Ophthalmol Vis Sci. 1994 Aug;35(9):3393-400
pubmed: 8056513
Invest Ophthalmol Vis Sci. 2014 Nov 18;55(12):8232-40
pubmed: 25406289

Auteurs

Catharina Busch (C)

Department of Ophthalmology, University Hospital Leipzig, Leipzig, Germany.

Matus Rehak (M)

Department of Ophthalmology, University Hospital Leipzig, Leipzig, Germany.

Margrit Hollborn (M)

Department of Ophthalmology, University Hospital Leipzig, Leipzig, Germany.

Peter Wiedemann (P)

Department of Ophthalmology, University Hospital Leipzig, Leipzig, Germany.

Gerhard K Lang (GK)

Department of Ophthalmology, University of Ulm Hospital, Ulm, Germany.

Gabriele E Lang (GE)

Department of Ophthalmology, University of Ulm Hospital, Ulm, Germany.

Armin Wolf (A)

Department of Ophthalmology, University of Ulm Hospital, Ulm, Germany.

Heidrun L Deissler (HL)

Department of Ophthalmology, University of Ulm Hospital, Ulm, Germany.

Classifications MeSH